PubMed HealthSearch

PubMed · 6534891

Studies with sucrose polyester.

Abstract

Sucrose polyester (SPE) is a lipid synthesized from sucrose and fatty acid methyl esters. SPE has physical and organoleptic properties that closely resemble triglycerides, but it is not hydrolysed in the intestine and therefore not absorbed. By providing a persistent lipophilic phase in the intestine, SPE reduces the absorption of lipophilic substances such as cholesterol. SPE leaves the stomach more rapidly than triglyceride oils, presumably because of the absence of an effect on duodenal receptors. In studies with obese subjects, dietary SPE reduced total and LDL cholesterol by reducing the absorption of cholesterol from the intestine. In a study, in which SPE was covertly substituted for dietary fat, ten obese subjects in a weight-loss regimen did not increase dietary intake to compensate for the energy removed from the diet by SPE substitution. In a similar study with five naive, obese subjects, the investigators concluded that the mean energy intake decrease during SPE treatment [184 (769 kJ) kcal/d] was not significant. SPE continues to be studied as a means of reducing energy intake.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R J Jandacek. 1984. Studies with sucrose polyester.. https://pubmed.ncbi.nlm.nih.gov/6534891/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Liposomal cyclosporine. Characterization of drug incorporation and interbilayer exchange.

A number of previous studies have examined the application of liposomes as carriers for the immunosuppressive agent cyclosporine. These studies, however, have generated equivocal results, particularly with regard to the therapeutic properties of such systems. In the present work, we have characterized cyclosporine incorporation into well defined liposomes, large unilamellar vesicles, and have examined the stability of drug association. Contrary to some earlier reports, we show that only modest levels of cyclosporine can be accommodated in the liposomal membrane and that the extent of drug incorporation is greatly reduced as the bilayer cholesterol content is increased. Furthermore, we demonstrate that cyclosporine, despite its hydrophobic character, can rapidly exchange between vesicles. This raises the possibility that, after i.v. administration, drug migration to other blood components might negate the potential benefits arising from liposomal delivery. In a companion paper, therefore (Choice et al., Transplantation, 1995, this issue), we have followed the pharmacokinetics and biodistribution of liposomal cyclosporine in a study that examined the behavior of both the drug and the liposomal carrier.

Cholesterol